Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, significantly improving outcomes for various malignancies. Despite their clinical success, only a subset of patients benefits from ICIs treatment, underscoring the need for innovative strategies to enhance their therapeutic po...
Saved in:
Main Authors: | Ting Zhang, Fanlin Gu, Wei Lin, Haiyan Shao, Aiguo Jiang, Xingang Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1611299/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01) -
A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01) -
Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity
by: Yanhong Liu, et al.
Published: (2025-03-01) -
Predicting prognosis and immunotherapy response of ferroptosis-related genes in colorectal cancer
by: Hongyun Wei, et al.
Published: (2025-06-01) -
Response to “Commentary on Ferroptosis, M6A and immune checkpoint-related gene expression in the middle temporal gyrus of the Alzheimer's disease brain”
by: Jingwen Hu, et al.
Published: (2025-06-01)